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1. Introduction
  The human immunodeficiency virus (HIV) pandemic has 
spread to all areas of the world, and the infection continues 
to be associated with high rates of morbidity and mortality, 
particularly in developing countries[1]. Two thirds of all 
persons with HIV infection and 60% of all women with HIV 
infections live in Sub-Saharan Africa[2]. Nigeria has the 
third largest number of people living with HIV in the world 
with a national prevalence of 4.6% and an estimated 2.98 
million people living with the HIV virus accounting for 9% 
of the global HIV burden[3].
  In spite of the above facts, only 34% of people with HIV 
infection are receiving antiretroviral drugs in Nigeria[4]. 
Combination therapies of antiretroviral (ARV) drugs are the 
treatment of choice in HIV infection.
  The World Health Organization (WHO) estimates that about 
80% of people living in Africa use traditional medicines 
for the management of their prevailing diseases and about 
two-thirds of AIDs patients in developing countries use 
traditional herbal medicines[5,6].
  This high use of traditional medicines may be due to 
accessibility, affordability, availability and acceptability of 
traditional herbal medicines by majority of the population 
in developing countries. Majority of the traditional herbal 
medicines are provided by practitioners who live within the 
communities, have been trusted over time, share similar 
cultural and spiritual beliefs and are always willing to assist 
the patients with their knowledge and skills, sometimes at 
minimal costs to the patients. However, traditional medicine 
practices differ according to culture, location and category 
of healer[7], and range from the more ubiquitous traditional 
doctor who uses herbal and other medicinal preparations 
for treating diseases (i.e. the herbalist), the diviner who 
operates within a traditional religious supernatural 
context and acts as a medium with the ancestral shades 
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and the faith healer who integrates religious rituals and 
traditional practices[8]. Patients including those with HIV/
AIDS have been known to consult all groups of traditional 
medical practitioners to various degrees[9-11] and for various 
reasons, most importantly because it meets their needs and 
expectations, and they are personalized and pay special 
respect to social and spiritual matters[12].
  In Africa, traditional medicines and natural health products 
are often used as primary HIV treatment and as therapy for 
HIV-related symptoms including dermatological disorders, 
nausea, depression, insomnia and weakness[13]. However, 
in spite of various interventions by development partners 
and some national governments, majority of AIDS patients 
have no access to standard care of management in Africa. 
Such a situation leaves the patients with only one option 
which is to use herbal medicines[14]. In recognition of this, 
several countries have taken steps. The WHO reports that 
as in 2006, 99 out of 120 countries surveyed have classified 
herbal medicines as over the counter products making them 
easily accessible to the public[15]. According to the South 
African Department of Health (2004), the continuum of care 
developed for the HIV and AIDS care and treatment program 
should involve traditional health practitioners as an essential 
and irreplaceable component of the comprehensive care 
provided[16]. Studies have reported that many patients take 
a broad range of traditional and natural health products in 
addition to their conventional therapeutic products[17-19] and 
some governments actively promote the use of traditional 
medicines with antiretroviral treatments, even in the midst 
of paucity of evidence on effectiveness and the possibility of 
harm[20,21].
  Some clinicians may not even know that their patients 
are actually using traditional medicines. In one study, 64% 
of patients stated that their treating doctors were aware of 
their use of traditional or alternative medicine, although, 
only a few of the clinicians had advised their patients to 
discontinue the use of these therapies[22]. Studies have 
reported conflicting findings in the efficacy and toxicities 
of traditional medicines in HIV/AIDS. While Tshibangu 
et al[23], Adewunmi and Ojewole[24] reported significant 
health improvement in clinical and laboratory indices in 
AIDS patients using traditional medicine, Erast[25] reported 
psychiatric and neurological adverse effects due to improper 
use, intrinsic toxicity of ingredients, contaminations 
and adulteration of preparations and interactions with 
conventional drugs. Prescriptions to take toxic plants for 
HIV treatment have been reported to result in severe adverse 
events, including death[26]. Studies by Edward Mills and 
colleagues demonstrated clear in vitro toxicities associated 
with traditional herbal medicines used in the treatment 
of HIV/AIDS patients in several southern African States, 
warning that biologically active constituents of these herbal 
remedies clearly may have an effect on HIV drug metabolism 
as a result of their inhibitory activity on enzymes and efflux 
drug transporter systems. They further highlighted the need 
for serious clinical studies in humans to unveil possible 
drug interactions of these herbal agents and antiretrovirals 
and that failure to do this may result in unidirectional drug 
interactions that may put patients at risk for treatment 
failure, viral resistance or drug toxicity. This will also have 
serious implication for adherence and general attitude to 
ARVs. As widespread as the phenomenon of traditional 
medicine use among patients with HIV infection, few data 
are available on the prevalence and patterns of traditional 
medicine use[27].
  The aim of this study was therefore to determine the 
prevalence of use of traditional medicine, the socio 
demographic distribution and attitude to antiretroviral 
therapy amongst patients with HIV infection attending the 
Virology Clinic of the Aminu Kano Teaching Hospital, 
Kano, North Western Nigeria.
2. Materials and methods
  This study was designed as a cross sectional prospective 
study using structured pretested questionnaires.
  The location of the study was the S.S. Wali Virology Center 
at the Aminu Kano Teaching Hospital, Kano, a tertiary 
health institution that serves as a referral center for three 
States in North Western Nigeria. It also serves as a center 
for testing, counseling, treatment and distribution of free 
antiretroviral drugs provided by the Federal Government in 
partnership with its global partners. The center attends to all 
patients with HIV infection diagnosed within the hospital or 
referred from outside the health facility.
  Patients recruited into the study were adults of either sex at 
15 years old age and above, who presented at the center with 
a previous or new diagnosis of HIV infection, irrespective of 
co-morbid status and had commenced antiretroviral therapy 
for at least three months.
  A total of 430 patients with diagnosed HIV infection 
were recruited into the study. Participants were recruited 
intermittently but consecutively for eight weeks from 
2nd April to 4th June, 2009. Researchers and translators 
were present to ensure complete understanding and avoid 
misinterpretations. All patients met the basic requirements 
and were given informed consent after the objective and 
details of the study had been explained.  No incentives were 
offered to patients approached for inclusion to limit bias.
  The study commenced after approval had been granted 
by the Ethical Committee of the Aminu Kano Teaching 
Hospital. Structured pretested questionnaires were 
administered on the patients by the researcher and 
translators. The questions were mainly close ended with 
a few open ended questions. The questionnaires elicited 
patients’ demographics, including age, sex, marital status, 
educational status, economic status (i.e. how much does the 
patient earn in a month), sexual preference, sexual habit 
(i.e. number of sexual partners); other questions sought to 
know if patient had used traditional medicine before coming 
to hospital for commencement of antiretroviral therapy 
(ART), whether patient was still on traditional medicine even 
having commenced ART.  We also sought to know if patient 
had ever missed a dose of antiretroviral drugs in the last six 
months or since commencement, and whether patients’ ARV 
drug regimen had been changed by the doctor in last six 
months or since commencement of ART.
  Data collected were entered into prepared Microsoft Excel 
database. Analysis was done using SPSS version 16.0. The 
chi square test was applied for evaluating associations. 
Statistical significance was concluded as P value < 0.05. 
Simple frequency distribution tables were used to display 
results.
3. Results
  Out of 430 patients recruited into the study, 400 gave 
effective response and so only these data were analyzed. 
Table 1 shows the socio-demographic distribution of 
patients studied.  There were 131 (32.8%) males and 269 
(67.2%) females with a male:female ratio of 1:2.1. The mean 
age of the study population was (33.6依8.4) years old. A total 
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of 76 (19%) were 16-25 years, 181 (45.3%) were 26-35 years, 
107 (16.8%) were 36-45 years, and 36 (9.0%) were above 46 
years. 
  Only 48 (12%) of the study population earned above 35 000 
naira (230 USD) per month while 266 (66.5%) earned less than 
10 000 naira (65.8 USD) per month.
  Out of the 400 patients whose data were analyzed, 110 
(27.5%) admitted to using traditional medicine at home 
before their commencement of the antiretroviral therapy. 
However, only 17 patients (4.3%) used traditional medicine 
and antiretroviral drugs concurrently.  Table 1 also displays 
the socio-demographic features of the groups taking ARV 
and traditional medicine concurrently.
  Two main indices were used to assess patient’s attitude 
to antiretroviral therapy with a view to finding out their 
adherence to ARV. One hundred forty eight (37%) patients 
had their drug regimen changed at least once while 23 
(20.90%) patients receiving traditional medicine before ART 
and 5 (29.41%)  patients having two treatments had their 
drug regimen changed. A total of 28.8% HIV patients, 14.6% 
patients used traditional medicine before ART and 29.4% 
concurrent users had missed at least a dose of their ARVs 
since commencement of therapy.
  A significant association was found between the economic 
status of the patients under study and the sexual habit 
(P=0.044). However, there was no significant association 
between the use of traditional medicine and patients 
adherence to antiretroviral therapy (P>0.05).  Nevertheless 
certain trends were observed.  
4. Discussion
  The majority of patients in the study population as well 
as those concurrently using ARV drugs and traditional 
medicine are females, and had achieved at least primary 
education. This demographic distribution is consistent with 
the epidemiological data of HIV positive patients reported 
by Ajayi et al and Uzochukwu et al in Nigeria[28,29] and 
Malangu et al in South Africa[30]. It also reflects the pattern 
of access to treatment in this environment. Women have 
been reported to be more susceptible to HIV infection 
due to hormonal changes, vaginal microbial ecology and 
physiology and a higher prevalence of sexually transmitted 
diseases[31,32]. Peltzer et al[33] as well as Malungu[30] had 
shown a predominance of women using the services of 
traditional herbal practitioners and traditional medicine.  In 
Pfeltzer’s study, 80% (n=222) were female, 59.4% were at 18 
to 35 years old and 81% had Grade 9 or higher education. 
This study as well as others previous ones may imply an 
emphasis on the health seeking behavior of women and the 
belief in the spiritual influences that touch the daily lives of 
people making them seek traditional medical practitioners, 
rather than modern health services. It also reinforces the 
fact that education has not successfully changed their 
acceptance of the spiritual influence on diseases as a highly 
prevalent notion in African societies[33].
  The prevalence rate is 4.25% in concurrent use of 
traditional medicine and Antiretroviral drugs, and it is 4.4% 
in Malangu’s report[31], while Sinsana et al[34] reported 1.1% 
prevalence in South Africa. A much higher prevalence of 
44.4% had been reported by Peltzer et al[33]. This is still far 
below the figure of 75% reported by Turner BJ[36].  These wide 
differences could be explained by cultural and economic 
reasons as different patients belief systems, social and 
sometimes economic factors may play significant roles in 
their decisions to use traditional medicine.  Underreporting 
may also account for the low prevalence figures in some 
studies including this one. This is expected in subjective 
methods of measurements.  There is a significant difference 
between the number of patients who were taking traditional 
medicine before their commencement of ART and those 
taking ARVs and traditional medicine concurrently. It is 
conceivable that some patients may have decided to drop 
one for the other because of side effects or may have been 
advised to do so by health workers.  Indeed, while some 
clinicians may not be aware that their patients are actually 
using traditional medicines, one study had reported that 64% 
of patients claimed that their treating doctors were aware of 
their use of traditional medicine although only a few of the 
clinicians had advised their patients to discontinue the use 
of these therapies.
  Some clinicians may not have discouraged their patients 
from the use of these therapies[22]  even as safety concerns 
continue to limit positive encouragement by others.
  More patients (29.4%) concurrently using ART and 
traditional medicine missed at least a dose of their 
ARVs in the last six months compared to those taking 
traditional medicine before ART but who stopped using 
it on commencement of therapy. Furthermore, a greater 
proportion of patients (29.4%) on concurrent ART and 
traditional medicine also had their ARV regimen changed 
as compared to those who took traditional medicine but 
stopped before commencing ART (14.6%). Ironically, a 
comparable proportion (28.8%) of patients who never took 
traditional medicine in the general study population missed 
at least a dose of their ARV in the last six months while 
a much higher proportion (37.0%) of them had their drug 
regimen changed within the period under consideration. 
The implication of this finding is interesting as adherence 
to therapy is perhaps the most important factor in treatment 
failure and the development of resistance[37].  While 71.2% 
Table 1    
Socio-demographic distribution of all patients in the study [n(%)]
Variables All patients
Patients taking traditional
medicine+ARV
Male 131 (32.8)   7 (41.2)
Female 267 (67.2) 10 (58.8)
Educational status
No formal education 118 (29.5)   6 (35.3)
Primary school   59 (14.8)   2 (11.8)
Secondary school  123 (30.8)   4 (23.5)
Undergraduate education   58 (14.5)   2 (11.8)
Postgraduate education   42 (10.5)   3 (17.7)
Economic status
(thousand N/Month)
< 5  186 (46.5)   7 (41.2)
5-9   80 (20.0)   4 (23.5)
10-35   86 (21.5)   5 (29.4)
> 35   48 (12.0) 1 (5.9)
Marital status
Single   41 (10.2)   4 (23.5)
Married 255 (63.8)   9 (52.9)
Divorced 24 (6.0)  1 (5.9)
Widowed   80 (20.0)   3 (17.7)
Sexual habit
0 partner   3 (0.8)                 0 (0.0)
Single partner 238 (59.5) 10 (58.8)
2 partners 80 (20.0)
> 2 partners   79 (19.8)   3 (17.7)
Igbiks Tamuno et al./Asian Pacific Journal of Tropical Medicine (2011)152-155 155
of the general HIV infected population could be said to be 
100% adherent to ART, the figure is lower (69.6%) for patients 
on concurrent ARV and traditional medication.
  It is possible that biologically active constituents of these 
traditional herbal remedies may have an effect on HIV drug 
metabolism as a result of their inhibitory activity on enzymes 
and efflux drug transporter systems[21]. Furthermore, the 
usually “powerful” status ascribed to traditional medicine in 
this cultural setting may make some patients to be careless 
with their orthodox ARV drugs thus reducing their adherence 
to therapy.
  In conclusion, the widespread use of traditional medicine 
by patients living with HIV/AIDS should be of concern 
to clinicians and policy makers. As cultural values are 
an inherent part of health care and an important part of 
practicing evidence based health care[38] patients will 
continue to seek traditional healing systems as primary 
care especially as only a third of infected patients currently 
access antiretroviral drugs in Nigeria. In our environment, 
traditional medicine remains poorly researched and poorly 
regulated.  Local production of even the registered herbal 
medicines generally does not adhere to GMP principles[14]. 
As policy efforts continue to highlight the need for better 
recognition and standardization, there is a need for 
circumspection when utilizing traditional medicine in 
patients with HIV infection and clinical studies are needed 
to unveil possible drug interactions of these traditional 
medicines and antiretroviral drugs and also to better 
characterize the extent of use of traditional medicines in this 
population of patients.
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